New Armenian Medical Journal (ISSN: 1829-0825, E-ISSN: 1829-0825) is a prominent academic publication established by Yerevan State Medical University, dedicated to advancing the field of medicine through high-quality research and scholarly discourse. Located in Armenia, this journal serves as a vital platform for disseminating innovative findings and clinical practices, with a particular focus on the regional healthcare landscape as well as global health issues. While currently categorized in the lower quartile (Q4) of general medicine, it demonstrates a commitment to improving its impact factor and ranking, evidenced by its ongoing publication from 2009 to 2024. The journal embraces a diverse scope that encompasses miscellaneous topics within medical research, catering to the needs of practitioners, researchers, and students alike. Though not an open-access journal, it offers valuable insights and knowledge that contribute meaningfully to the medical community. By participating in this scholarly dialogue, readers can enhance their understanding and foster advancements in the ever-evolving field of medicine.

Welcome to the Journal of Taibah University Medical Sciences, a distinguished open-access publication dedicated to advancing knowledge in the field of medicine. Since its inception in 2006, and published by ELSEVIER, this journal has become a vital resource for researchers and healthcare professionals alike, reflecting a steadfast commitment to disseminating innovative research and high-quality medical studies. With an impressive impact factor and a Scopus ranking placing it in the top 25% of general medicine journals, this publication occupies a notable position in the academic landscape. The journal covers a wide array of topics within the medical sciences, from clinical research to public health initiatives. As a Q3 category journal in the 2023 rankings, it continues to attract submissions that contribute meaningfully to the diverse and evolving field of medicine, supporting an open-access model that ensures widespread accessibility to its invaluable content. Explore the Journal of Taibah University Medical Sciences to stay abreast of the latest scientific advancements and engage with fellow scholars across the globe.

Biomedical Reports, published by SPANDIDOS PUBL LTD in Greece, is a distinguished open-access journal that focuses on the dynamic fields of biochemistry, genetics, molecular biology, medicine, pharmacology, and neuroscience. Established in 2014, the journal has rapidly gained recognition, securing Q2 and Q3 rankings in several categories for 2023, including a notable ranking of #125/636 in General Medicine, placing it in the 80th percentile amongst its peers. The journal continually aims to disseminate innovative research findings that advance the understanding of complex biomedical issues, making it an invaluable resource for researchers, professionals, and students alike. Its multidisciplinary approach not only reflects the interconnectivity of modern biomedical sciences but also promotes collaborative discourse among diverse fields, ensuring ongoing relevance and impact within the scientific community.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

MEDICAL SCIENCE MONITOR is a prominent peer-reviewed journal published by Int Scientific Information, Inc., dedicated to the field of medicine and healthcare. Established in 1997, this journal serves as a vital platform for disseminating high-quality research and innovative findings in a range of medical disciplines. With a commendable Q2 quartile ranking in Medicine (Miscellaneous) for 2023, it ranks amongst the top 11% of journals in its category according to Scopus, showcasing its significant impact in the medical community. Notably, the journal's general medicine ranking of 65 out of 636 further underscores its relevance and authority in the field. Although the journal operates via a non-open access model, it remains highly accessible to researchers, professionals, and students alike, fostering an environment of knowledge sharing and collaboration. As an ongoing commitment to advancing medical science, MEDICAL SCIENCE MONITOR continues to publish cutting-edge research until 2024, making it an essential resource for anyone passionate about medicine and healthcare innovations.

Indonesian Biomedical Journal, published by PRODIA EDUCATION & RESEARCH INST, serves as a vital platform for the dissemination of groundbreaking research in the fields of biochemistry, genetics, and molecular biology, as well as general medicine. Since its inception, this Open Access journal has made significant strides in enhancing accessibility to scientific knowledge, allowing researchers, professionals, and students to engage with high-quality studies without financial barriers. With an ISSN of 2355-9179 and a focus on emerging biomedical topics, the journal has established itself in the academic community, securing Q3 and Q4 rankings in its respective categories for 2023. The journal's commitment to maintaining a rigorous peer-review process ensures that only the most innovative and impactful research is published, fostering an environment that encourages collaborative learning and discovery. As it converges from 2017 to 2024, the Indonesian Biomedical Journal continues to be an essential resource for those involved in advancing biomedical sciences, particularly within the unique context of Indonesia and beyond.

Pathologia is a prominent open-access journal dedicated to advancing the field of clinical and experimental pathology, published by ZAPORIZHZHYA STATE MEDICAL UNIVERSITY. Established in 2013, the journal aims to provide a platform for researchers, clinicians, and students to share innovative research, case studies, and reviews that are critical to understanding disease mechanisms and improving diagnostic and therapeutic strategies. With a steady commitment to high-quality research dissemination and accessibility, this journal serves as an essential resource for those in the medical and health sciences fields. Researchers engaging with Pathologia can explore a diverse range of topics, including histopathology, molecular pathology, and laboratory medicine, promoting both scholarly discussion and practical applications. The journal's open-access model ensures that vital research findings are freely available to the global academic community, fostering a collaborative environment that is crucial for the advancement of pathology as a discipline.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

ANNALS OF MEDICINE, published by Taylor & Francis Ltd, stands as a leading journal in the field of medical research, holding a prestigious Q1 ranking within the miscellaneous medicine category as of 2023. With a focus on disseminating high-quality, peer-reviewed research, the journal provides a vital platform for scholars, clinicians, and policy-makers to share innovative findings that advance the understanding and practice of medicine. Established in 1961, ANNALS OF MEDICINE has continuously evolved, promoting interdisciplinary approaches and fostering collaboration among researchers across various medical specialties. Its impressive Scopus rank of #103 out of 636, representing the top 83rd percentile in general medicine, underscores its influence and importance in the medical community. Although it does not offer Open Access options, the journal remains committed to maintaining rigorous academic standards, making it an essential resource for anyone dedicated to improving healthcare outcomes through scholarly research.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.